Summit Securities Ltd

{"description":"Market sentiment in September is expected to remain volatile following the Modi-Xi meeting and the SCO Summit 2025, according to Prashanth Tapse, Sr VP Research Analyst at Mehta Equities Ltd.","url":"https://www.msn.com/en-in/money/markets/what-to-expect-from-indian-stock-market-in-september-after-modi-xi-meeting-sco-summit-2025/ar-AA1LGJQ2?ocid=BingNewsVerp","sentiment":"Neutral","domain":"Mint on MSN"}

{"description":"Gift Nifty traded at 24,759, a 30-point premium over Nifty futures' previous close, signaling a positive start for Indian stock market indices amid updates from the SCO Summit 2025 and RBI data.","url":"https://www.msn.com/en-in/money/markets/indian-stock-market-8-things-that-changed-for-market-overnight-gift-nifty-sco-summit-2025-to-rbi-data/ar-AA1LFHm2?ocid=BingNewsVerp","sentiment":"Neutral","domain":"Mint on MSN"}

{"description":"AstraZeneca is in advanced talks for a $15 billion oncology licensing deal, highlighting its position as a leading high-growth stock, according to a Bloomberg report.","url":"https://finance.yahoo.com/news/summit-astrazeneca-azn-advanced-talks-142512389.html","sentiment":"Positive","domain":"Yahoo Finance"}

{"description":"Summit Therapeutics and AstraZeneca are in talks for a potential partnership deal valued at up to $15 billion, according to Bloomberg News.","url":"https://www.msn.com/en-us/money/savingandinvesting/summit-astrazeneca-in-talks-over-15-billion-partnership-deal-bloomberg-news-reports/ar-AA1HUo6N?ocid=BingNewsVerp","sentiment":"Positive","domain":"Reuters on MSN"}